State Street’s Neurogene NGNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.15M Sell
210,848
-19,690
-9% -$294K ﹤0.01% 3139
2025
Q1
$2.7M Buy
230,538
+5,165
+2% +$60.5K ﹤0.01% 3135
2024
Q4
$5.15M Sell
225,373
-21,167
-9% -$484K ﹤0.01% 2960
2024
Q3
$10.3M Buy
246,540
+36,687
+17% +$1.54M ﹤0.01% 2585
2024
Q2
$7.64M Buy
209,853
+178,626
+572% +$6.5M ﹤0.01% 2728
2024
Q1
$1.59M Buy
+31,227
New +$1.59M ﹤0.01% 3353
2023
Q4
Sell
-6,128
Closed -$96.8K 4472
2023
Q3
$96.8K Hold
6,128
﹤0.01% 4122
2023
Q2
$102K Hold
6,128
﹤0.01% 4235
2023
Q1
$85.8K Hold
6,128
﹤0.01% 4367
2022
Q4
$62.4K Hold
6,128
﹤0.01% 4504
2022
Q3
$78K Hold
6,128
﹤0.01% 4543
2022
Q2
$126K Sell
6,128
-23,153
-79% -$476K ﹤0.01% 4412
2022
Q1
$1.1M Buy
29,281
+282
+1% +$10.6K ﹤0.01% 3774
2021
Q4
$2.8M Sell
28,999
-1,522
-5% -$147K ﹤0.01% 3529
2021
Q3
$4.41M Sell
30,521
-31,234
-51% -$4.52M ﹤0.01% 3304
2021
Q2
$11.4M Sell
61,755
-17,198
-22% -$3.17M ﹤0.01% 2841
2021
Q1
$19.4M Buy
78,953
+20,085
+34% +$4.94M ﹤0.01% 2385
2020
Q4
$16.6M Buy
58,868
+31,039
+112% +$8.75M ﹤0.01% 2348
2020
Q3
$6.68M Buy
27,829
+2,472
+10% +$593K ﹤0.01% 2651
2020
Q2
$8.42M Buy
25,357
+24,669
+3,586% +$8.19M ﹤0.01% 2515
2020
Q1
$157K Buy
688
+80
+13% +$18.3K ﹤0.01% 3592
2019
Q4
$150K Hold
608
﹤0.01% 3659
2019
Q3
$35K Hold
608
﹤0.01% 3740
2019
Q2
$29K Hold
608
﹤0.01% 3752
2019
Q1
$33K Hold
608
﹤0.01% 3692
2018
Q4
$26K Sell
608
-1,062
-64% -$45.4K ﹤0.01% 3707
2018
Q3
$98K Buy
1,670
+78
+5% +$4.58K ﹤0.01% 3655
2018
Q2
$84K Buy
1,592
+293
+23% +$15.5K ﹤0.01% 3646
2018
Q1
$366K Buy
1,299
+238
+22% +$67.1K ﹤0.01% 3475
2017
Q4
$250K Buy
1,061
+378
+55% +$89.1K ﹤0.01% 3544
2017
Q3
$193K Buy
683
+98
+17% +$27.7K ﹤0.01% 3607
2017
Q2
$164K Hold
585
﹤0.01% 3540
2017
Q1
$195K Buy
585
+15
+3% +$5K ﹤0.01% 3507
2016
Q4
$188K Hold
570
﹤0.01% 3497
2016
Q3
$153K Sell
570
-25
-4% -$6.71K ﹤0.01% 3419
2016
Q2
$78K Buy
+595
New +$78K ﹤0.01% 3560